A decrease in body weight, blood pressure, HbA1c, fasting insulin, insulin resistance, plasma glucagon, total cholesterol, lipids, FPG, SMBG, cardiovascular death, nonfatal stroke, and myocardial infarction are observed with the use of semaglutide in monotherapy or in combination with other antidiabetic drugs
Bai XJ, Hao JT, Zheng RH, et al
Its effects can vary widely depending on factors like dosage, duration of use, and individual skin type
Start the assessment: Step 2: Provider Evaluation & Eligibility Review A licensed Hims provider reviews your intake to determine whether GLP-1 medication is appropriate
Supporting Skin Elasticity and the "Ozempic Face" Phenomenon The term "Ozempic Face" has gained traction in the media to describe the sagging or aged appearance that can sometimes follow rapid weight loss